Artelo presents phase 1 data for FABP5 inhibitor ART26.12

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Entera Bio presents Phase 1 data on single-tablet EB613 Hisse Senetleri 0 16
A Crinetics presents phase 2 data for CAH treatment atumelnant Hisse Senetleri 0 21
A Upstream Bio presents positive Phase 2 trial data for verekitug Hisse Senetleri 0 12
A Agios presents detailed mitapivat trial results for sickle cell Hisse Senetleri 0 22
A Intellia presents Phase 3 results for HAE gene therapy lonvo-z Hisse Senetleri 0 14
A Disc Medicine presents trial data for blood disorder treatments Hisse Senetleri 0 18
A Form 13G Artelo Biosciences For: 3 April Hisse Senetleri 0 18
A Artelo Biosciences stock surges on glaucoma study agreement Hisse Senetleri 0 47

Benzer konular

Üst